CompletedNot Applicable

Therapeutic Plasma Exchange in Thyrotoxicosis

27 participantsStarted 1999-01-01

Plain-language summary

Therapeutic plasma exchange (TPE) is indicated in cases where antithyroid medications cannot be used due to the side effects or attain no adequate hormonal suppression response at the highest dosage and in cases of rapid onset of clinical symptoms. This study presents the treatment results of patients who underwent TPE and subsequently operated for thyrotoxicosis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * thyrotoxicosis unresponsive to medication * adverse reaction to the medications * need for rapid treatment in patients that need urgent surgery Exclusion Criteria: * The patients who did not undergo surgery post-therapeutic plasma exchange * Preoperative hypocalcemia, * hemodynamically unstable patients * patients not suitable for central catheter placement

What they're measuring

Thyroid hormone levels of patients after therapeutic plasma exchange

Timeframe: 1 week before the operation

Trial details

NCT IDNCT04485975

SponsorBaskent University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-02-01

View on ClinicalTrials.gov More Thyrotoxicosis trials